Contact
Please use this form to send email to PR contact of this press release:
Genmab Announces that the patents asserted against DARZALEX® in the United States have been declared invalid by summary judgment.
TO:
Please use this form to send email to PR contact of this press release:
Genmab Announces that the patents asserted against DARZALEX® in the United States have been declared invalid by summary judgment.
TO: